Insider Shareholders with Direct Ownership of Catalyst Biosciences, Inc. (CBIO)
This section provides a comprehensive overview of the insiders with direct ownership of Catalyst Biosciences, Inc. (CBIO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CATALYST BIOSCIENCES, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Eddie Williams
Director |
20,237 | 0 | 34,804 $0 | 6 |
Jan 07, 2022
Added 26.12%
|
|
Geoffrey M.D. Ling
Director |
25,155 | 0 | 31,790 $0 | 6 |
Jan 07, 2022
Added 28.79%
|
|
Errol B Desouza
Director |
15,174 | 0 | 29,801 $0 | 5 |
Oct 01, 2021
Added 10.75%
|
| 24,573 | 24 | 24,573 $0 | 6 |
Oct 01, 2021
Added 19.2%
|
|
|
Grant E. Blouse
Chief Scientific Officer |
7,663 | 0 | 9,417 $0 | 3 |
Aug 09, 2022
Added 25.66%
|
| 76,401 | 63,476 | 1,636 $0 | 14 |
Jun 28, 2024
Reduced 67.85%
|
|
|
Howard Levy
Chief Medical Officer |
639 | 0 | 639 $0 | 1 |
Aug 09, 2021
Added 50.0%
|
|
Seline E. Miller
SVP Finance; Interim CFO & PAO |
6,500 | 6 | 0 $0 | 3 |
Aug 31, 2023
Reduced 100.0%
|
| 19,353 | 28 | 0 $0 | 7 |
Aug 31, 2023
Reduced 100.0%
|
|
| 0 | 6,266 | 0 $0 | 1 |
Aug 31, 2023
Reduced 100.0%
|
|
| 0 | 5,371,304 | 0 $0 | 1 |
Oct 27, 2023
Reduced 100.0%
|